Development of novel small molecule MerTK and Flt3 tyrosine kinase inhibitors for treatment of acute leukemia

Date 02 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session New drugs and targets in hematological malignancies
Topics Anti-Cancer Agents & Biologic Therapy
Drug Development
Leukaemia
Presenter Douglas Graham